1. Efficacy and safety of tofacitinib for treatment of rheumatoid arthritis;Lundquist;World J. Orthop.,2014
2. The effectiveness of tofacitinib, a novel janus kinase inhibitor, in the treatment of rheumatoid arthritis: a systematic review and meta-analysis;Kawalec;Clin. Rheumatol.,2013
3. Impact of methotrexate discontinuation, interruption, or persistence in US patients with rheumatoid arthritis initiating tofacitinib + oral methotrexate combination;Cohen;Clin. Ther.,2022
4. Xeljanz/Xeljanz XR Clinical Pharmacology, (n.d.). https://www.pfizermedicalinformation.com/en-us/xeljanz/clinical-pharmacology (accessed November 2, 2022).
5. Rp-Hplc method development and validation for the quantification of tofacitinib;Siva;Res. J. Life Sci. Bioinform. Pharm. Chem. Sci.,2018